Nucleix
Irina Gerlovin has been working in the scientific field since 2007. Irina began their career as a Research Assistant at Quark Pharmaceuticals, where they worked for 13 years. In 2020, they joined Nucleix Ltd. as a Product Development Scientist.
Irina Gerlovin completed their Bachelor's degree in Biochemistry and food science at Hebrew University of Jerusalem. Robert H. Smith Faculty of Agriculture, Food and Environment between 2001 and 2004. Irina then went on to obtain their Master's degree in Biology and Biochemistry from Bar-Ilan University between 2004 and 2007.
This person is not in any offices
Nucleix
Nucleix is a global leader in creating cancer diagnostic panels based on epigenetic biomarkers. Backed by OrbiMed and other leading investors, Nucleix provides a strong pipeline of products for various cancer types.